biomarkers for glp-1 agonists Frontiers The Role of GLP-1RA Medications
Description
[PubMed] Wilding JPH, Batterham RL, Calanna S, et al
Santiago JA, Karthikeyan M, Lackey M, Villavicencio D, Potashkin JA
Nature Communications
The global market for GLP-1 weight-loss medications alone was valued at around $13.84 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 18.54%, reaching nearly $48.84 billion by 2030
Rivals are flooding in, with dozens of compounds already in mid- to late-stage trials
